4-1BB ligand induces cell division, sustains survival, and enhances effector function of CD4 and CD8 T cells with similar efficacy

Journal of Immunology

Volumn 167, Issue 3, 2001, Pages 1313-1324

  Cannons, J L ^a   Lau, P ^a   Ghumman, B ^a   DeBenedette, M A ^a   Yagita, H ^a   Okumura, K ^a   Watts, T H ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CD27 ANTIGEN; CD28 ANTIGEN; CD3 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 2; INTERLEUKIN 4; LIGAND;

ANIMAL CELL; ARTICLE; CELL DIVISION; CELL FUNCTION; CELL SURVIVAL; CYTOKINE PRODUCTION; EFFECTOR CELL; HELPER CELL; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SUPPRESSOR CELL; T LYMPHOCYTE ACTIVATION;

EID: 0035423265     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.167.3.1313     Document Type: Article

References (58)

1. CD28/B7 system of T cell costimulation
2. Co-stimulation in T cell responses
3. Role of 4-1BB in immune responses
4. OX-40: Life beyond the effector T cell stage
5. Tumor necrosis factor receptor family members in the immune system
6. T cell costimulatory molecules other than CD28
7. Molecular cloning of a ligand for the inducible T cell gene 4-1BB: A member of an emerging family of cytokines with homology to tumor necrosis factor
8. 4-1BB T cell antigen binds to mature B cells and macrophages, and costimulates anti-μ-primed splenic B cells
9. - T lymphocytes by 4-1BB ligand
10. - T cells
11. CD28-independent, TRAF2-dependent costimulation of resting T cells by 4-1BB ligand
12. Analysis of 4-1BB ligand-deficient mice and of mice lacking both 4-1BB ligand and CD28 reveals a role for 4-1BB ligand in skin allograft rejection and in the cytotoxic T cell response to influenza virus
13. Costimulation of antigen-specific CD4 T cells by 4-1BB ligand
14. Role of 4-1BB ligand in costimulation of T lymphocyte growth and its upregulation on M12 B lymphomas by cAMP
15. Signals through 4-1BB are costimulatory to previously activated splenic T cells and inhibit activation-induced cell death
16. Human 4-1BB regulates CD28 co-stimulation to promote Th1 cell responses
17. Amplification of tumor immunity by gene transfer of the co-stimulatory 4-1BB ligand: Synergy with the CD28 co-stimulatory pathway
18. 4-1BBL co-operates with B7-1 and B7-2 in converting a B cell lymphoma cell line into a long lasting anti-tumor vaccine
19. 4-1BB ligand, a member of the TNF family, is important for the generation of antiviral CD8 T cell responses
20. 4-1BB costimulation is required for protective anti-viral immunity after peptide vaccination
21. Monoclonal antibodies against the 4-1BB T-cell activation molecule eradicate established tumors
22. + T cell proliferation and lead to the amplification in vivo of cytotoxic T cell responses
23. Cutting edge: 4-1BB is a bonafide CD8 T cell survival signal
24. Role of TNF receptor-associated factor 2 and p38 mitogen-activated protein kinase activation during 4-1BB-dependent immune response
25. Differential T cell costimulatory requirements in CD28-deficient mice
26. Tolerance induction in double specific T-cell receptor transgenic mice varies with antigen
27. Duration of TCR stimulation determines costimulatory requirement of T cells
28. 10 thymocytes in vivo
29. Antigen recognition by H-2 restricted T cells. II. A tryptic ovalbumin peptide that substitutes for processed antigen
30. Establishment and characterization of BALB/c lymphoma lines with B cell properties
31. Identification and distribution of the costimulatory receptor CD28 in the mouse
32. The major histocompatibility complex-restricted antigen receptor on T cells. I. Isolation with a monoclonal antibody
33. d
34. Critical contribution of OX40 ligand to T helper cell type 2 differentiation in experimental leishmaniasis
35. Induction of costimulatory molecule B7 in M12 B lymphomas by cAMP or MHC-restricted T cell interaction
36. Following the fate of individual T cells throughout activation and clonal expansion: Signals from T cell receptor and CD28 differentially regulate the induction and duration of a proliferative response
37. Regulation of 4-1BB expression by cell-cell interactions and the cytokines, interleukin-2 and interleukin-4
38. Distinct roles for LFA-1 and CD28 during activation of naive T cells: Adhesion versus costimulation
39. Determination of lymphocyte division by flow cytometry
40. Two distinct stages in the transition from naive CD4 T cells to effectors, early antigen-dependent and late cytokine-driven expansion and differentiation
41. + T cell proliferation and effector function in vivo
42. + T cells in vitro is largely dependent on exogenous cytokines
43. Ligation of 4-1BB (CDw137) regulates graft-versus-host disease, graft-versus-leukemia, and graft rejection in allogeneic bone marrow transplant recipients
44. CD27 is required for generation and long-term maintenance of T cell immunity
45. OX40-ligand has a critical costimulatory role in dendritic cell: T cell interactions
46. Impairment of antigen-presenting cell function in mice lacking expression of OX40 ligand
47. OX40-deficient mice are defective in Th cell proliferation bur are competent in generating B cell and CTL responses after virus infection
48. Robust B cell immunity but impaired T cell proliferation in the absence of CD134 (OX40)
49. OX-40 ligand: A potent costimulatory molecule for sustaining primary CD4 T cell responses
50. Danger and OX40 receptor signaling synergize to enhance memory T cell survival by inhibiting peripheral deletion
51. Activation of OX40 signal transduction pathways leads to tumor necrosis factor receptor-associated factor (TRAF) 2- and TRAF5-mediated NF-κB activation
52. CD27, a member of the tumor necrosis factor receptor superfamily, activates NF-κB and stress-activated protein kinase/c-Jun N-terminal kinase via TRAF2, TRAF5, and NF-κB-inducing kinase
53. 4-1BB and OX40 are members of a tumor necrosis factor (TNF)-nerve growth factor receptor subfamily that bind TNF receptor-associated factors and activate nuclear factor κB
54. Human 4-1BB (CD137) signals are mediated by TRAF2 and activate nuclear factor-κB
55. The TNFR2-TRAF signaling complex contains two novel proteins related to baculoviral inhibitor of apoptosis proteins
56. The c-1AP-1 and c-1AP-2 proteins are direct inhibitors of specific caspases
57. Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis c-1AP2 is under NF-κB control
58. Thermodynamic characterization of the interaction between TRAF2 and tumor necrosis factor receptor peptides by isothermal titration calorimetry